TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #104 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #104 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#116 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #116 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #116 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
Treatment: untreated control Sex: female Age:15 years Tissue: bone |
Permissive
|
Homo sapiens |
GSE110800
...
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
Treatment:2hr after irradiation with 10Gy (1Gy/min) Sex: female Age:15 years Tissue: bone |
Permissive
|
Homo sapiens |
GSE110800
...
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
Treatment:4hr after irradiation with 10Gy (1Gy/min) Sex: female Age:15 years Tissue: bone |
Permissive
|
Homo sapiens |
GSE110800
...
|
MA0106.3
|
TP53 |
IMR90 (lung fibroblasts) |
Treatment: etoposide (100uM, 6hrs) Source: IMR90 fetal lung fibroblasts Passage: #30-35 |
Permissive
Robust
|
Homo sapiens |
GSE115940
...
|
MA0106.3
|
TP53 |
SW480 (colon adenocarcinoma) |
treatment: TNF for 16hr Celltype: colon cancer cells Genotype: stable control (LacZ) knockdown |
Permissive
|
Homo sapiens |
GSE115985
...
|
MA0106.3
|
Showing 10 records in page 9
from 18 pages